Next Article in Journal
Development of Myasthenia Gravis in a Patient with Chronic Myeloid Leukemia during Treatment with Nilotinib
Previous Article in Journal
TET2 Promoter DNA Methylation and Expression Analysis in Pediatric B-Cell Acute Lymphoblastic Leukemia
 
 
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prevalence of Thrombophilic Gene Polymorphisms in an Azari Population of Iran

by
Nasrin Bargahi
1,
Malak Farajzadeh
1,
Ahmad Poursadegh-Zonouzi
2 and
Davoud Farajzadeh
1,2,*
1
Department of Genetic, Biotechnology Research Center, Research and Development Complex, Tabriz University of Medical Sciences, Tabriz 5166614711, Iran
2
Department of Cellular and Molecular Biology, Faculty of Biological Science, Azarbaijan Shahid Madani University, Tabriz 5375171379, Iran
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2014, 6(2), 5321; https://doi.org/10.4081/hr.2014.5321
Submission received: 24 January 2014 / Revised: 27 February 2014 / Accepted: 24 March 2014 / Published: 22 April 2014

Abstract

There is several evidence suggests that thrombophilic gene polymorphisms may influence susceptibility to thromboembolic events. The prevalence of these polymorphisms is different in various races and ethnics. Accordingly, we studied the prevalence of Factor V (G1691A and A4070G), prothrombin G20210A and PAI-1 4G/5G in healthy northwest population of Iran. In this prospective study, 500 healthy individuals, who had no history of both personal and family history of thromboembolic disorders, were selected as a sample of healthy population in northwestern Iran. Genotyping of these polymorphisms was performed using the amplification refractory mutation system-polymerase chain reaction method. No significant differences were detected between the expected and observed frequencies of FV G1691A and A4070G, prothrombin G20210A polymorphisms (p > 0.05), while the expected frequency of 4G allele was significantly more than observed frequency in the studied population (p < 0.01). These findings were compared with other reports from various populations. In conclusion, the allele frequency for FV G1691A and PAI-1 4G/5G polymorphisms showed relative consistency compared to those of previous studies, while the incidence pattern of FV A4070G polymorphism in Northwestern population of Iran showed conflicting results regarding other studied population. The prothrombin G20210A polymorphism was observed at a higher frequency than other studied populations.
Keywords: thromboembolism; Factor V; prothrombin; plasminogen activator inhibitor-1 thromboembolism; Factor V; prothrombin; plasminogen activator inhibitor-1

Share and Cite

MDPI and ACS Style

Bargahi, N.; Farajzadeh, M.; Poursadegh-Zonouzi, A.; Farajzadeh, D. Prevalence of Thrombophilic Gene Polymorphisms in an Azari Population of Iran. Hematol. Rep. 2014, 6, 5321. https://doi.org/10.4081/hr.2014.5321

AMA Style

Bargahi N, Farajzadeh M, Poursadegh-Zonouzi A, Farajzadeh D. Prevalence of Thrombophilic Gene Polymorphisms in an Azari Population of Iran. Hematology Reports. 2014; 6(2):5321. https://doi.org/10.4081/hr.2014.5321

Chicago/Turabian Style

Bargahi, Nasrin, Malak Farajzadeh, Ahmad Poursadegh-Zonouzi, and Davoud Farajzadeh. 2014. "Prevalence of Thrombophilic Gene Polymorphisms in an Azari Population of Iran" Hematology Reports 6, no. 2: 5321. https://doi.org/10.4081/hr.2014.5321

Article Metrics

Back to TopTop